Literature DB >> 6275783

Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole.

R H Eng, A Person, C Mangura, H Chmel, M Corrado.   

Abstract

Susceptibility to amphotericin B, miconazole, and ketoconazole was determined for 25 clinical isolates of zygomycetes in yeast nitrogen base broth and human serum. In yeast nitrogen base broth, 7 of 25 isolates were susceptible to an imidazole or amphotericin B. In serum, all were resistant to the imidazoles and inhibited by amphotericin B, the current drug of choice for infections caused by zygomycetes.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6275783      PMCID： PMC181775          DOI： 10.1128/AAC.20.5.688

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  7 in total

1.  In vitro activity of amphotericin B on strains of Mucoraceae pathogenic to man.

Authors:  D C WATSON; P B NEAME
Journal:  J Lab Clin Med       Date:  1960-08

2.  Rhinocerebral phycomycosis in association with diabetic ketoacidosis. Report of two cases and a review of clinical and experimental experience with amphotericin B therapy.

Authors:  E Abramson; D Wilson; R A Arky
Journal:  Ann Intern Med       Date:  1967-04       Impact factor: 25.391

3.  Susceptibility of Zygomycetes to human serum.

Authors:  R H Eng; M Corrado; E Chin
Journal:  Sabouraudia       Date:  1981-06

4.  An evaluation of two years of clinical experience with ketoconazole.

Authors:  J Symoens; M Moens; J Dom; H Scheijgrond; J Dony; V Schuermans; R Legendre; N Finestine
Journal:  Rev Infect Dis       Date:  1980 Jul-Aug

5.  The activity of ketoconazole in mixed cultures of fungi and human fibroblasts.

Authors:  F Aerts; M De Brabander; H van den Bossche; J van Cutsem; M Borgers
Journal:  Mykosen       Date:  1980-02

Review 6.  Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives.

Authors:  M Borgers
Journal:  Rev Infect Dis       Date:  1980 Jul-Aug

Review 7.  Mucormycosis.

Authors: 
Journal:  Ann Intern Med       Date:  1980-07       Impact factor: 25.391
  7 in total
  4 in total

Review 1.  Systemic zygomycosis.

Authors:  E W Benbow; R W Stoddart
Journal:  Postgrad Med J       Date:  1986-11       Impact factor: 2.401

Review 2.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

Review 3.  Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections.

Authors:  Prit Lakhani; Akash Patil; Soumyajit Majumdar
Journal:  J Ocul Pharmacol Ther       Date:  2018-11-08       Impact factor: 2.671

4.  Acute Cardiac Failure due to Intra-Atrial Mass Caused by Zygomycetes in an Immunocompromised Paediatric Patient.

Authors:  G J van de Glind; C E M Gidding; C M W Verlaat; K Duthoi; A P C Backx; P E Verweij; A Warris
Journal:  Case Rep Med       Date:  2010-07-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.